Recent studies have provided strong evidence that patients with heart failure can benefit from medical therapies that can reduce risk of worsening symptoms and extend patients' lives. But despite new guidelines, adoption ...
Mar 6, 2023
0
9
In a world-first randomized study, catheter ablation has been shown to reverse heart failure with preserved ejection fraction (HFpEF) in patients with both HFpEF and atrial fibrillation (AF).
Mar 2, 2023
0
36
Physician-scientists at The Texas Heart Institute announced today the results of the largest cell therapy trial to date in patients with chronic heart failure due to low ejection fraction. The therapy benefited patients by ...
Feb 27, 2023
0
410
According to a new article in Cardiovascular Innovations and Applications, sodium-glucose cotransporter-2 (SGLT2) inhibitors have been found to ameliorate major adverse cardiovascular events in patients with heart failure ...
Feb 16, 2023
0
1
Baker Heart and Diabetes researchers have found that middle-aged women with a small heart have low cardiorespiratory function (CRF). Lower cardiorespiratory function is associated with disability, heart failure and premature ...
Feb 10, 2023
0
20
With modern therapies for heart failure (HF) with reduced ejection fraction (HFrEF), some patients can improve their cardiac function during treatment. But despite this improvement in the ability of their hearts to pump, ...
Dec 15, 2022
0
8
Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled clinical tools have to be easily available and used.
Nov 1, 2022
0
21
Clinical data and cardiac magnetic resonance (CMR) imaging did not improve risk prediction for sudden cardiac death (SCD) after myocardial infarction in the largest pooled patient cohort collected to date. The late breaking ...
Aug 29, 2022
0
4
Researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, presented new evidence that drugs originally developed to treat type 2 diabetes may benefit a wide range of patients ...
Aug 29, 2022
0
7
Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease, according to late breaking ...
Aug 29, 2022
0
13
